Latest News

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Science

Channels:

New Theory on Mystery of Fairy Circles of Namibia, Caves in Central China Show History of Natural Flood Patterns, Regional Sea-Level Scenarios Will Help Northeast Plan for Faster-Than-Global Rise, and More in the Environmental Science News Source

The latest research on the environment in the Environmental Science News Source

Science

Channels:

Gates Foundation, Danforth Center, Sorghum, Africa, Plant Science, ARPA-E, Food Security

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 25-Jan-2017 8:00 AM EST

Medicine

Channels:

Tablet Apps, Medication Adherence, Drug Eluting Stent, Heart Health

App Improves Medication Adherence for Heart Stent Patients

Heart-screengrab.jpg

A tablet computer application helped heart patients with drug-eluting stents take their medications correctly, a study from the University of Illinois at Chicago has found. Researchers found that patients in the intervention group had a 10 percent higher medication possession ratio than patients in the control group.

Medicine

Channels:

dry eye, seasonal dry eye

Tips to Treat Seasonal Dry Eye

If your eyes feel like the Sahara desert or your vision seems blurrier than usual, don’t panic. It may just be seasonal dry eye.

Medicine

Channels:

VF, Autoimmune Disorders, Autoimmunity, Vasculitis

The Vasculitis Foundation 2017 Patient & Family Vasculitis Baltimore Regional Conference

The Vasculitis Foundation will hold its 2017 Baltimore Regional Conference on Saturday, February 4, in Bethesda, Maryland.

Life

Law and Public Policy

Channels:

Trump Presidency to Affect the Quality of Financial Reporting Info, Laws of Nature Trump Politics When It Comes to Climate Change, Do Politicians Need Pop Stars? and More in U.S. Politics News Source

Go here for the latest political experts, features and research in U.S. Politics

Science

Channels:

A Quark Like No Other, Biophysics Plays Key Role in Immune System Signaling and Response, ALMA Reveals Sun in New Light, and MORE in the Physics News Source Sponsored by AIP

Click here to go directly to the Physics News Source Sponsored by AIP.

Medicine

Channels:

Sinusitis, Otolaryngology, Clinical Trial

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 23-Jan-2017 7:00 AM EST

Medicine

Channels:

Social Environment, Health, mice

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 25-Jan-2017 2:00 PM EST

Medicine

Channels:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 23-Jan-2017 3:00 PM EST

Business

Channels:

Mindfulness Based Stress Reduction, Anxiety

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 24-Jan-2017 10:00 AM EST

Medicine

Channels:

Tau Tangles, tau, Alzheimer Disease & Associated Disorders, Tauopathy, Oligonucleotides

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 25-Jan-2017 2:00 PM EST

Medicine

Channels:

Stem Cells, Immunotherapy, Cancer, zika virus, Infectious Diseases, Pregnancy, Public Health, Pediatrics, Neurology, Natural Killer Cells

CIRM Approves New Funding to UC San Diego Researchers Fighting Zika Virus and Cancer

muotri_cirm.jpg

The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) has approved a pair of $2 million awards to University of California San Diego School of Medicine researchers to advance studies of new treatments for Zika virus infections and the use of stem cell-derived natural killer (NK) cells to target ovarian cancer and other malignancies.

Science

Channels:

How Much Drought Can a Forest Take?

131221_web_1.jpg

Aerial tree mortality surveys show patterns of tree death during extreme drought.

Medicine

Channels:

Daughter’s Hearing Loss Inspired JTC Alumni Parent to Help More Children in Need

Capture-300x179.jpg

Learning of her daughter’s hearing loss set this mother on a journey half way across the globe to John Tracy Clinic to receive help for her child. Her experiences inspired her to help change the way treatment is handled in her home country of India.

Life

Education

Channels:

Northwestern University, Medill School of Journalism, Education, Journalism

Pulitzer Center Panel Features Front-Line Journalists on Cuba

The Medill School of Journalism, Media, Integrated Marketing Communications will host an impressive slate of journalists with recent reporting experience in Cuba for a panel discussion about the country’s uncertain future.The panel discussion is part of Medill’s new partnership with the Pulitzer Center on Crisis Reporting, a nonprofit organization, based in Washington D.

Medicine

Channels:

Depression, Dialysis

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 26-Jan-2017 5:00 PM EST

Medicine

Channels:

laboratory technology, cell reprogramming, Precision Medicine, Cancer Drug, Cells

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 26-Jan-2017 11:00 AM EST

Life

Education

Channels:

Higher Education, higher education administration, Leadership, Academia, Academic appointment, Global Academic Programs, Academic Degrees, Interdisciplinary Studies, academic partnerships

Rahmat Shoureshi, Ph.D., Begins Role as Interim President of New York Institute of Technology

Rahmat_Shoureshi_NYIT.jpg

Rahmat Shoureshi, Ph.D., will become the interim president of New York Institute of Technology (NYIT) on Jan. 21, 2017, according to NYIT Board of Trustees Chair Kevin Silva.

Medicine

Channels:

triple negative breast cancer, Drug Resistance, trametinib

Researchers Unlock Mechanism of Drug Resistance in Aggressive Breast Cancer

LisaCareyHorizontal.jpg

In the journal Cancer Discovery, UNC Lineberger Comprehensive Cancer Center researchers and colleagues report findings of how triple negative breast cancer cells are able to bypass treatment with trametinib, a U.S. Food and Drug Administration-approved drug that belongs to a class of commonly used anti-cancer drugs called kinase inhibitors. The researchers also reported findings from laboratory models of breast cancer testing a potential treatment approach that could prevent the onset of resistance.







Chat now!